These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8223403)

  • 41. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monoclonal antibodies to the influenza A virus matrix protein that react with viral strains of different subtypes].
    Popov IA; Chervonskiĭ AV; Krivoshein IuS; Krivorutchenko IuL; Bakova AA; Fedorkina OA
    Vopr Virusol; 1992; 37(3):141-4. PubMed ID: 1441439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.
    Sultana I; Gao J; Markoff L; Eichelberger MC
    Vaccine; 2011 Mar; 29(14):2601-6. PubMed ID: 21288802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses.
    Liu Y; Liu X; Fang J; Shen X; Chen W; Lin X; Li H; Tan W; Wang Y; Zhao P; Qi Z
    Vaccine; 2010 Dec; 29(2):183-90. PubMed ID: 21055499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.
    Mills KH
    Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
    Takahashi Y; Hasegawa H; Hara Y; Ato M; Ninomiya A; Takagi H; Odagiri T; Sata T; Tashiro M; Kobayashi K
    J Infect Dis; 2009 Jun; 199(11):1629-37. PubMed ID: 19385735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
    Brown LE; Murray JM; White DO; Jackson DC
    Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane-anchored stalk domain of influenza HA enhanced immune responses in mice.
    Gao D; Chen Y; Han D; Qi Q; Sun X; Zhang H; Feng H; Wang M
    Microb Pathog; 2017 Dec; 113():421-426. PubMed ID: 29174687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
    Yoshikawa T; Suzuki Y; Nomoto A; Sata T; Kurata T; Tamura Si
    Vaccine; 2002 Nov; 21(1-2):60-6. PubMed ID: 12443663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the primary structure of the influenza virus hemagglutinin.
    Skehel JJ; Waterfield MD
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):93-7. PubMed ID: 1054518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
    Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype-specific L3T4+ T cell clones.
    Thomas DB; Skehel JJ; Mills KH; Graham CM
    Eur J Immunol; 1987 Jan; 17(1):133-6. PubMed ID: 2434337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin.
    Smith CA; Barnett BC; Thomas DB; Temoltzin-Palacios F
    J Exp Med; 1991 Apr; 173(4):953-9. PubMed ID: 1706753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative investigation of monoclonal and polyclonal antibodies directed against strain-specific and common antigenic sites on influenza H1N1 virus hemagglutinin.
    Drescher J; Verhagen W; Flik J; Stachan R
    Intervirology; 1987; 27(4):205-17. PubMed ID: 2447032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.